Published in Volume
101, Issue 5 (March 1, 1998)
J Clin Invest. 1998;101(5):1148–1155.
doi:10.1172/JCI659.
Copyright ©
1998, The American Society for
Clinical Investigation.
4 citations have been reported for this article.
Research Article
Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells.
A H Limper, M Edens, R A Anders and E B Leof
Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care, and Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Published March 1, 1998
Pneumocystis carinii remains an important cause of pneumonia in patients with AIDS. Attachment of the organism to epithelial cells is a central event in establishing infection, impairing the growth potential of lung epithelial cells and thereby slowing repair. In light of investigations documenting a central role for cyclin-dependent kinases in controlling the cell cycle, we addressed the hypothesis that P. carinii inhibits epithelial cell growth by interfering with host epithelial cyclin-dependent kinase (cdk) activity. We observed that P. carinii significantly impaired growth of cultured mink lung epithelial cells, with effects observed after 48-72 h of treatment. However, the kinase activity associated with p34cdc2 or p33cdk2 was maximally inhibited as early as 24 h after P. carinii exposure. The inhibitory effect on cyclin-dependent kinase activity was mediated by the trophozoite form of P. carinii, in that highly purified trophozoites exerted marked inhibition of p34cdc2 activity. Growth impairment was similarly preceded by P. carinii-induced alteration in the state of epithelial cell p34cdc2 phosphorylation, with no change in p34cdc2 or p33cdk2 protein levels. These data strongly suggest that the antiproliferative activity of P. carinii on respiratory epithelium is mediated in part through modulation of the host cell cycle machinery.